Pharmaceutical Company
Active 2007–2026. The register lists this client once for every firm that files on its behalf; all 28 of its records are shown together here.
These two figures are not added together. A client that lobbies for itself reports its own spending, while firms it retains report what they were paid. Disclosure rules ask the in-house figure to include those payments, but filings do not always do so, and a filing gives no way to tell. Each is shown as reported.
| Year | Firm | Period | Amount | Doc |
|---|---|---|---|---|
| 2016 | PFIZER INC. |
4th Quarter (Oct 1 - Dec 31) AMENDED |
$2,110,000 | |
| 2016 | PFIZER INC. |
3rd Quarter (July 1 - Sep 30) AMENDED |
$1,670,000 | |
| 2016 | PFIZER INC. |
2nd Quarter (Apr 1 - June 30) AMENDED |
$2,820,000 | |
| 2016 | PFIZER INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$2,060,000 | |
| 2016 | NVG, LLC |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$70,000 | |
| 2016 | ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$80,000 | |
| 2016 | FEDERAL POLICY GROUP, LLC |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$90,000 | |
| 2016 | ERNST & YOUNG LLP (WASHINGTON COUNCIL ERNST & YOUNG) |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$20,000 | |
| 2016 | THE DUBERSTEIN GROUP INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$100,000 | |
| 2016 | THE WASHINGTON TAX & PUBLIC POLICY GROUP |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$40,000 |
| Issue | Activities |
|---|---|
| Health Issues | 401 |
| Taxation/Internal Revenue Code | 367 |
| Trade (domestic/foreign) | 270 |
| Medicare/Medicaid | 240 |
| Copyright/Patent/Trademark | 210 |
| Budget/Appropriations | 110 |
| Pharmacy | 72 |
| Consumer Issues/Safety/Products | 59 |
| Alcohol and Drug Abuse | 45 |
| Defense | 25 |
| Agriculture | 17 |
| Labor Issues/Antitrust/Workplace | 13 |
| Environment/Superfund | 12 |
| Tariff (miscellaneous tariff bills) | 7 |
| Animals | 5 |